Boston Scientific (BSX) stock rose modestly early Wednesday after the medtech company reported adjusted income of 62 cents per share on $4.12 billion in second-quarter sales.
↑
X
How To Buy Stocks: Profit From Earnings Reports Using This Option Strategy
On average, analysts polled by FactSet expected Boston Sci to earn 58 cents a share on $4.02 billion in sales.
During the year-earlier period, the company earned 53 cents per share and reported nearly $3.6 billion in sales.
For the year, Boston Scientific raised its EPS guidance slightly to $2.38-$2.42 on 13.5%-14.5% sales growth. Wall Street expected $2.33 earnings per share and $16.02 billion in sales.
In premarket action on the stock market today, Boston Scientific stock rose 2%. Shares were already at record highs.
Shares have a strong IBD Digital Composite Rating of 96 out of a best-possible 99. This means Boston Sci stock ranks in the leading 4% of all stocks when it comes to fundamental and technical measures. Boston Scientific stock is currently trading at a record high.
More to follow.
Follow Allison Gatlin on X, the platform formerly known as Twitter, at @IBD_AGatlin.
YOU MAY ALSO LIKE:
Medical Giant Danaher Nears Breakout On This ‘Stark Contrast’ With A Key Rival
The ‘Shocking’ And ‘Alarming’ Report That Sent IBD 50’s Medpace Into A Nosedive
IBD Stock Of The Day: See How To Find, Track And Buy The Best Stocks
إرسال تعليق